Literature DB >> 22341587

Resistant Kawasaki disease treated with anti-CD20.

Emilie Sauvaget1, Béatrice Bonello, Marion David, Brigitte Chabrol, Jean-Christophe Dubus, Emmanuelle Bosdure.   

Abstract

We report the case of a 6-year-old boy who had Kawasaki disease resistant to intravenous immunoglobulin and systemic steroids. Because of an uncontrolled disease course, with significant lesions of the coronary arteries, anti-CD20 treatment was used. Rapid clinical, biological, and cardiac improvement was observed. The patient tolerated the treatment well.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22341587     DOI: 10.1016/j.jpeds.2012.01.018

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  8 in total

1.  Immunoglobulin Resistance in Kawasaki Disease.

Authors:  Georgios A Hartas; Syed Shahrukh Hashmi; Chi Pham-Peyton; Emmanouil Tsounias; John T Bricker; Monesha Gupta-Malhotra
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2015-03-01       Impact factor: 1.349

Review 2.  Treatment Options for Resistant Kawasaki Disease.

Authors:  Linny Kimly Phuong; Nigel Curtis; Peter Gowdie; Jonathan Akikusa; David Burgner
Journal:  Paediatr Drugs       Date:  2018-02       Impact factor: 3.022

3.  TNF-α blockers for the treatment of Kawasaki disease in children.

Authors:  Noyuri Yamaji; Katharina da Silva Lopes; Tetsuo Shoda; Kazue Ishitsuka; Tohru Kobayashi; Erika Ota; Rintaro Mori
Journal:  Cochrane Database Syst Rev       Date:  2019-08-16

4.  Monoclonal antibody therapy for Kawasaki disease: a protocol for systematic reviews and meta-analysis.

Authors:  Osamu Nomura; Sayaka Fukuda; Erika Ota; Hiroshi Ono; Akira Ishiguro; Tohru Kobayashi
Journal:  Syst Rev       Date:  2016-04-12

5.  Autoimmune Hemolytic Anemia and Immune Thrombocytopenia: A Unique Presentation of Kawasaki Disease.

Authors:  Chloe Kupelian; Bindu Sathi; Deepika Singh
Journal:  Case Rep Rheumatol       Date:  2021-02-27

6.  Clinical use of biologics in vasculitis syndromes.

Authors:  Marino Paroli
Journal:  Biologics       Date:  2012-10-25

Review 7.  Kawasaki disease: pathophysiology, clinical manifestations, and management.

Authors:  Victoria R Dimitriades; Amanda G Brown; Abraham Gedalia
Journal:  Curr Rheumatol Rep       Date:  2014-06       Impact factor: 4.686

Review 8.  Kawasaki Disease: an Update.

Authors:  Eileen Rife; Abraham Gedalia
Journal:  Curr Rheumatol Rep       Date:  2020-09-13       Impact factor: 4.592

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.